GSK plc - 07 Aug 2025 SCHEDULE 13D Report for CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)

Filing Manager: GSK plc
Reporting Manager: GSK plc
Security: CureVac N.V. Common Shares, par value (euro) 0.12 per share
Symbol: CVAC
Shares outstanding: 22,421,536 shares
Disclosed Ownership: 16,591,937 shares
Ownership: 74%
Form type: SCHEDULE 13D
Filing time: 13 Aug 2025, 18:05:21 UTC
Date of event: 07 Aug 2025
Next filing: 05 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GSK plc	74%	16,591,937	16,591,937	0	/s/ Victoria A. Whyte	Victoria A. Whyte, Authorized Signatory	0001131399